Compounds > tosyllysine chloromethyl ketone

tosyllysine chloromethyl ketone and Wallerian Degeneration

tosyllysine chloromethyl ketone has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikegami, K; Kato, S; Koike, T	1

Other Studies

1 other study(ies) available for tosyllysine chloromethyl ketone and Wallerian Degeneration

Article	Year
N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) suppresses neuritic degeneration caused by different experimental paradigms including in vitro Wallerian degeneration. Brain research, 2004, Dec-24, Volume: 1030, Issue:1 Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Calcium; Cells, Cultured; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Neurites; Serine Proteinase Inhibitors; Sodium; Superior Cervical Ganglion; Tosyllysine Chloromethyl Ketone; Vinblastine; Wallerian Degeneration	2004

Article

Year

N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK) suppresses neuritic degeneration caused by different experimental paradigms including in vitro Wallerian degeneration.

Brain research, 2004, Dec-24, Volume: 1030, Issue:1

Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Calcium; Cells, Cultured; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Neurites; Serine Proteinase Inhibitors; Sodium; Superior Cervical Ganglion; Tosyllysine Chloromethyl Ketone; Vinblastine; Wallerian Degeneration

2004